Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Immunotherapy for Prostate Cancer: Treatments for the "Lethal" Phenotype.

The Urologic clinics of North America - 1 Nov 2020

Slovin Susan F

Abstract excerpt

Multiple immunologic platforms have provided minimal impact in patients with metastatic castration-resistant prostate cancer, necessitating that novel approaches continue to be developed. Although checkpoint inhibitors have been largely ineffective, there remain small cohorts of patients who have durable responses but lack the conventional indicators for response to this class of drugs, that is, high mutational...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Immunotherapy
Share to Biological Products
Share to Cancer Vaccines

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cyclin-Dependent Kinases

Share to Neoplasm Invasiveness

Share to Precision Medicine

Share to Prostatic Neoplasms, Castration-Resistant

Share to Tumor Microenvironment

Source

Open in PubMed Open full text

Identifiers

PMID: 33008497
DOI: 10.1016/j.ucl.2020.07.007
PMCID: PMC8796648

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Immunotherapy for Prostate Cancer: Treatments for the "Lethal" Phenotype.PMID 33008497Read ↗

New approaches and prospects of immunotherapy and gene therapy for prostate cancerSemantic proximity Read ↗

Precision Targets for Intercepting the Lethal Progression of Prostate Cancer: Potential Avenues for Personalized TherapySemantic proximity Read ↗

Emerging Biomarker-Guided Therapies in Prostate CancerSemantic proximity Read ↗

Treatment strategies for DNA repair-deficient prostate cancer.Semantic proximity Read ↗

PD-1/PD-L1 for prostate cancer: from clinical trials to practice.Semantic proximity Read ↗

The time for molecular phenotyping of metastatic castrate-resistant prostate cancer is now.Semantic proximity Read ↗

[Metastatic castration-resistant prostate cancer-emerging trends in therapy].Semantic proximity Read ↗

Molecular therapeutics in prostate cancer.Semantic proximity Read ↗

Beyond simple castration: targeting the molecular basis of treatment resistance in advanced prostate cancerSemantic proximity Read ↗

Contemporary Management of Prostate CancerSemantic proximity Read ↗

Novel Target Opportunities in Non-Metastatic Castrate Resistant Prostate CancerSemantic proximity Read ↗

Modeling prostate cancer in mice: limitations and opportunities.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.